DEVELOPMENT OF A DE NOVO MODEL TO ASSESS THE COST-EFFECTIVENESS OF A NEW TREATMENT OPTION FOR PATIENTS WITH PRIMARY IMMUNOGLOBULIN A NEPHROPATHY (IGAN)

被引：0
|
作者：
Davies, N. [1 ]
Dickinson, O. [1 ]
Downward, L. [2 ]
Pitcher, D. [2 ]
Gale, D. [3 ]
Ioannou, P. [1 ]
Kipentzoglou, K. [4 ]
Crabtree, M. [5 ]
机构：
[1] Mtech Access Ltd, Bicester, England
[2] UK Renal Registry, Bristol, BST, England
[3] UCL, London, England
[4] Britannia Pharmaceut Ltd, Reading, England
[5] STADA, Bad Vilbel, Germany
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE119
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [31] Cost-Effectiveness of Primary Prevention with Statin Treatment for Chinese Patients with Type 2 Diabetes
    Li, Te
    Wan, Xu
    Ma, Jin
    Wu, Bin
    ADVANCES IN THERAPY, 2018, 35 (12) : 2214 - 2223
  • [32] Cost-Effectiveness of Primary Prevention with Statin Treatment for Chinese Patients with Type 2 Diabetes
    Te Li
    Xu Wan
    Jin Ma
    Bin Wu
    Advances in Therapy, 2018, 35 : 2214 - 2223
  • [33] COST-EFFECTIVENESS OF SCREENING AND EARLY TREATMENT OF NEPHROPATHY IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS
    SIEGEL, JE
    KROLEWSKI, AS
    WARRAM, JH
    WEINSTEIN, MC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1992, 3 (04): : S111 - S119
  • [34] Cost-effectiveness of primary surgical versus primary medical management in the treatment of patients presenting with advanced glaucoma
    Kernohan, Ashleigh
    Homer, Tara
    Shabaninejad, Hosein
    King, Anthony J.
    Hudson, Jemma
    Fernie, Gordon
    Azuara-Blanco, Augusto
    Burr, Jennifer
    Sparrow, John M.
    Garway-Heath, David
    Barton, Keith
    Norrie, John
    Maclennan, Graeme
    Vale, Luke
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (10) : 1452 - 1457
  • [35] Primary therapist model for patients referred for rheumatoid arthritis rehabilitation: A cost-effectiveness analysis
    Li, Linda C.
    Maetzel, Andreas
    Davis, Aileen M.
    Lineker, Sydney C.
    Bombardier, Claire
    Coyte, Peter C.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (03): : 402 - 410
  • [36] Cost-effectiveness of new guidelines for adjuvant systemic therapy for patients with primary breast cancer
    Kievit, W
    Bolster, MJ
    van der Wilt, GJ
    Bult, P
    Thunnissen, FBJM
    Meijer, J
    Strobbe, LJA
    Klinkenbijl, JHG
    Wobbes, T
    Adang, EMM
    Beex, LVAM
    Tjan-Heijnen, VCG
    ANNALS OF ONCOLOGY, 2005, 16 (12) : 1874 - 1881
  • [37] An analytical model to predict the cost-effectiveness of long-term eszopiclone for the treatment of primary insomnia
    Snedecor, S. L.
    Botteman, M. F.
    Schaefer, K.
    Barry, N.
    Rubens, R.
    Pickard, A. S.
    VALUE IN HEALTH, 2007, 10 (06) : A381 - A382
  • [38] TREATMENT IN TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS IN MACEDONIA: DEVELOPMENT OF COST-EFFECTIVENESS ANALYSIS
    Qerimi, V
    Kapedanovska-Nestorovska, A.
    Sterjev, Z.
    Genadieva-Stavric, S.
    Suturkova, L.
    VALUE IN HEALTH, 2017, 20 (09) : A435 - A435
  • [39] DEVELOPMENT OF A MODEL TO ASSESS THE COST-EFFECTIVENESS OF THERAPIES FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) FOLLOWING A REFERENCE MODEL FRAMEWORK
    Aguiar-Ibanez, R.
    Palencia, R.
    Kandaswamy, P.
    Flavin, J.
    Gauthier, A.
    Davies, M. J.
    VALUE IN HEALTH, 2014, 17 (07) : A562 - A562
  • [40] Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease
    Spencer, M
    Briggs, AH
    Grossman, RF
    Rance, L
    PHARMACOECONOMICS, 2005, 23 (06) : 619 - 637
12345